Sort by
Refine Your Search
-
protein toxins for this exciting project. You will be part of the Microbes in Health and Disease research theme in Newcastle University Faculty of Medical Sciences, as part of an ERC funded collaborative
-
schemes and a number of health and wellbeing initiatives to support you. Closing Date: 30 April 2025 The Role The School of Engineering is seeking to appoint a Lecturer/Senior Lecturer (Teaching and
-
opportunity to interact with a broad range of researchers within the Newcastle Centre for Cancer, Newcastle University Biosciences Institute (NUBI) and more widely across the Faculty of Medical Sciences. NUBI
-
wellbeing initiatives to support you. Closing Date: 11 May 2025 Newcastle Health Research Partners (NHRP) – an Academic Health Science Centre (AHSC) – is seeking a dynamic and strategic Chief Operating
-
wellbeing initiatives to support you. Closing Date: 11 May 2025 Newcastle Health Research Partnership (NHRP) – an Academic Health Science Centre (AHSC) – is seeking a dynamic and strategic Chief Operating
-
the resulting measurements to constrain intrinsic alignment models. You will work with collaborators in the LSST Dark Energy Science Collaboration, and may also apply to join the Euclid Consortium. In
-
Research Associate Genetic and functional analysis of Gram positive secretion systems and substrates
of Gram-positive bacteria. You will be part of the Microbes in Health and Disease research theme in Newcastle University Faculty of Medical Sciences, as part of an ERC funded collaborative project
-
innovative design, development and research consultancy services since 1970. We operate in a collaborative and thriving hub based at Walker Riverside with close links to the School of Engineering in the city
-
, particularly those designed to increase accessibility and inclusion to science. The position is fixed-term, with full time hours (37 per week) and an estimated start date of 1 October, 2025 (candidates seeking a
-
are experts in the biology and treatment of childhood and adult leukaemia to leverage our unique datasets to identify biomarkers and help improve the outcome of patients with acute leukaemia. This is an